Related Experiment Video
Updated: Jun 28, 2026

04:18
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
Complement activation fragment Bb in early pregnancy and spontaneous preterm birth
Anne M Lynch1, Ronald S Gibbs, James R Murphy
1Department of Obstetrics and Gynecology, University of Colorado Denver, Denver, CO 80045, USA. anne.lynch@uchsc.edu
American Journal of Obstetrics and Gynecology
|October 22, 2008
Summary
Elevated levels of complement fragment Bb in early pregnancy significantly increase the risk of spontaneous preterm birth (SPTB) before 34 weeks gestation. This finding suggests early pregnancy inflammation plays a role in SPTB pathogenesis.
Area of Science:
- Reproductive Immunology
- Maternal-Fetal Medicine
- Complement System Biology
Background:
- Spontaneous preterm birth (SPTB) before 34 weeks gestation is a major obstetric concern.
- The role of early pregnancy inflammatory markers in SPTB is not fully understood.
Purpose of the Study:
- To investigate the association between elevated complement activation fragment Bb levels in early pregnancy and SPTB.
- To differentiate the association with early SPTB (<34 weeks) versus late SPTB (34-37 weeks).
Main Methods:
- Prospective study of 784 women enrolled before 20 weeks gestation.
- Measurement of complement activation fragment Bb levels.
- Statistical analysis to determine the risk of SPTB based on Bb quartiles.
Main Results:
- Women in the top quartile of Bb levels had a 4.7-fold increased likelihood of SPTB before 34 weeks gestation (P = .003).
- No significant association was found between Bb levels and late SPTB (34-37 weeks gestation).
Conclusions:
- Elevated Bb in early pregnancy is a significant predictor of early SPTB (<34 weeks).
- These findings support the hypothesis that inflammatory processes in early pregnancy contribute to the pathogenesis of SPTB.
Related Concept Videos
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...